Where does Valerio Therapeutics Société anonyme make most of its revenue?

Rest of The World: 73% of revenue by region in fiscal year 2025, followed by France (27%).

What companies are similar to Valerio Therapeutics Société anonyme?

Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Ipsen S.a. (IPN.PA), Transgene SA (TNG.PA), Oncodesign Precision Medicine Société anonyme (ALOPM.PA).

Valerio Therapeutics Société anonyme (ALVIO.PA) Stock

About Valerio Therapeutics Société anonyme

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degrad...

At a glance

Rest of The World was its largest region in fiscal year 2025, with 73% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2024.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.